Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Smitty .. the lack of excitement is due more to the Capital structure than the science.
It appears the insiders have given themselves hundreds of millions of shares
For very little $$$ .. which dilution for the rest of us and billions for them..
Just appears very greedy and that usually ends up terrible for other investors..
Let’s go save lives
I'm looking for another drug to take so I dont have to take the experimental mrna drugs they are pushing so hoping companies like Mountain can make progress here in US. I see and invest in alot of companies that have proven cures with existing drugs but cannot get through the fda process because they are not big enough to bribe everyone at fda, nih, faaucci. Lots of good therapeutics however none get thru phase 3, all held up until pfizer moderna have sold to everyone, big scam.
Over 4,000 deaths from those so called vaccines and no mention of that in media. Any other drug would have been pulled from market.
In US I would like to find doctors who will prescribe ivermectin, which has been around 50+ years.
Mountain should do well in other countries and hopefully we will see revenues soon.
Don’t worry about us
Save Brazil, India and phillipines
Good news, Another verification their tech works,
Mountain Valley MD Receives Successful Results From BSL-4 COVID-19 Clearance Trial on Three Variants Tested With Ivectosol
-A single dose of 2.5 milligrams per kilogram of Ivectosol™ was effective at interfering with viral replication and driving viral clearance of the B.1.1.7 COVID-19 variant.
-Tests done in vitro showed the same antiviral effect at 5uM Ivectosol™ concentration after 24 hours and again after 48 hours against all three COVID-19 variants tested - the original B.1.1.7 variant, the South African B.1.351 variant, and the P.1 Brazil variant.
Human trials will start quickly in other countries
India is already on their way with testing
Dr. John Clements is Emeritus Professor of Microbiology and Immunology at Tulane University School of Medicine, he needs to find a way to accelerate this in the US and Canada, may need to bring in a partner for US because the fda needs bribes to do anything
There is a base forming so low risk from here. Next will be news like this story at zerohedge. MDMV is mentioned because they have multiple items in process.
https://www.zerohedge.com/news/2021-05-14/investing-biotech-now-right-time
By end June will see lots of results, now is good time to add as this is probably the price bottom before all news.
This is release from MVMD saying the Drugs for animals will be large market for them not just here but in India. Chicken market along will take this stock higher.
Other nice part is doing the animal trials is easier and faster.
The Company has commenced husbandry animal trials validate the superiority of its injectable solubilized Ivermectin technology, Ivectosol™ 1%, versus current commercially available forms to treat a broad category of animal parasites.
The trials have commenced in Canada to study poultry, swine and cattle, and in Bangladesh to study poultry, goat and cattle. Initial feedback is the trial dosing was easily accomplished in the animals with the needleless applicator with no adverse reactions.
The preliminary study results for Canada are anticipated late June, 2021.
The preliminary study results for Bangladesh are anticipated early June, 2021.
Bot in yesterday, believe bottom is in, going up from here.
too much news coming in next 3 months that will maintain & grow interest in this stock.
Like their pipeline of projects even though they are small company. Only need one to hit with the technology. Drug delivery companies have an advantage when developing products because they are using proven drugs so only need to prove their conversion works.
NBC L.A. interview broadcast last night with MIKE FARBER
https://cdn-ceo-ca.s3.amazonaws.com/1g8jsja-trim.E13BF919-F8B8-4B58-B1BF-A454B255292A.MOV
Bangladesh needs to show India what’s up with the Ivermectin efficacy!
https://www.indiatvnews.com/news/world/us-defends-restrictions-export-of-covid-19-vaccine-raw-materials-india-request-to-lift-ban-699897
Buckle up! April/May will beauties. BSL4 lab test results which are VERY relevant right now with ongoing pandemic concerns, government meetings in Bangladesh which will bring us commercialization contracts, plus much more I'm sure! MASSIVE short float about to get squeezed. Perfect storm. Don't get left behind.
Hello? Anyone here? Crickets.....April should be a huge month for MVMDF;)
So.. half truths can scare the crap out of retail and seeking alpha has many posters deeply in bed with shorts..
I always approach Seeking Alpha articles with extreme caution as more often than not they have an agenda.
Some of the things they reference are of concern, for sure, and they should be fully investigated and (hopefully) addressed by the company. Quoting anonymous sources is the lowest form of reporting as the information provided by those sources can not be verified. I spoke to 6 different super duper highly qualified mega smart scientists who’s names I can’t share because they don’t want the fame and fortune that goes with being identified with their opinions, and 5 out of 6 said Mountainview is the best thing they’ve seen since the discovery of bread slicing, and they feel the other anonymous scientists are just bitter because they lost at poker last night. The other anonymous scientist didn’t agree with the 5, and said the science couldn’t possibly be true because it hasn’t been endorsed by Oprah. I swear that this is all true. You can trust me because I’m posting this on an anonymous forum on the internet
Yea, I saw that too. Serious shade/hit piece. Anyone have any insight on the info provided? I hope that management comes back with some sort of counter.
Look what I just saw on SeekingAlpha: https://seekingalpha.com/article/4415895-mountain-valley-md-aggressive-stock-promotion-and-hollow-science-100-downside
Anyone have any info or insight??
Well I’m glad to be wrong.
i understand from whence this thought derived..
wait for it...
This company is always going to have another Gargantuan Deal in the wings.
i dont necessarily beleive in Gap Filling..but..
looks like a previous gap down has been filled..now the last Gap up has been filled..now we can start running..without the gaps please..
and north! just to be clear...
Here is the News!
https://assets-global.website-files.com/60085ac8fa8263a049a4d1b4/6050b8056e49c91349b8eec8_PR%202021-03-16%20-%20MVMD%20Commencing%20Trials%20in%20%20Bangladesh%2C%20Striking%20Pharma%20Production%20Agreements.pdf
Quick Re-Cap,
India produces and uses a lot of IVermectin for people and livestock.
Great Choice to SPEED the TIMELINE!
Impressed
Someone probably bought them out to prevent Ivermectin use. Just my opinion.
Anything from anyone?
You never know..
The volume wasn’t heavy But maybe they felt like someone had access to news before market..
Jumped .14 in under an hour on the Canadian exchange just before the halt. Not huge volume though
Yes .. that is pos. Add with stock in green before stop.. may not re open until tokorrow
Appears that way, at least it was by the company and not something else.
you never know...could be bad news too..
You like seeing green befor a midday stop..
This seems like a very long stop..
No massive volume before.. so not an imbalance stop..
Fingers croosed
I’m seeing the same thing on the Canadian market. Announcement?
https://www.mountainvalleymd.com/pipeline
just saw insulin....i know you are supposed to d your
due dilligence BEFORE
you buy a stock..
believer in ivermectin..come on MVMD..
Wow! Kevin O'Leary speaks up on MVMD...
https://www.reddit.com/r/CanadianInvestor/duplicates/lsdsl5/kevin_oleary_shares_thoughts_on_cdn_biotech/
Very strong support.
$MVMDF Mountain Valley MD Holdings to Commence Trading on OTCQB Market Under Ticker MVMDF
Press Release | 02/12/2021
Mountain Valley MD Holdings to Commence Trading on OTCQB Market Under Ticker MVMDF
Canada NewsWire
TORONTO, Feb. 12, 2021
TORONTO, Feb. 12, 2021 /CNW/ - Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE: MVMD) (FRA: 20MP) is pleased to announce that effective February 16, 2021, it will graduate from the OTC Pink Sheets ("OTCPK") and commence trading on the OTCQB Venture Marketplace ("OTCQB") under the symbol "MVMDF".
Mountain Valley MD Holdings Inc. (CNW Group/Mountain Valley MD Holdings Inc.)
The OTCQB is operated by OTC Markets Group Inc. ("OTC") out of New York City, NY. The OTC operates the world's largest electronic interdealer quotation system for US broker dealers and offers multiple media channels to increase the visibility of OTC-listed companies. Trading on the OTCQB Market enables companies to efficiently build broader investor awareness and provide U.S. investors with a seamless trading facility to more easily trade through the broker of their choice.
Investors can find Real-Time quotes and market information for MVMD on www.otcmarkets.com. The Company continues to trade on the Canadian Securities Exchange under the ticker symbol "MVMD" and the Frankfurt Stock Exchange under the ticker symbol "20MP".
"Trading on the OTCQB is an excellent advancement that will provide a large U.S. investor base with the opportunity to participate directly in Mountain Valley MD's growth," stated Dennis Hancock, President and CEO of Mountain Valley MD Holdings. "The OTC listing will contribute to our strategy to continue to enhance our share liquidity and broaden the reach and awareness of our global health and wellness innovations."
ABOUT OTC MARKET GROUP INC
OTC Markets Group Inc. operates the OTCQX Best Market, the OTCQB Venture Market and the Pink Open Market for 10,000 U.S. and global securities. Through OTC Link ATS and OTC Link ECN, the company connects a diverse network of broker-dealers that provide liquidity and execution services. OTC Markets enables investors to easily trade through the broker of their choice and enable companies to improve the quality of information available for investors.
The OTCQB Venture Market is the premiere marketplace for early stage and developing U.S. and international companies that are committed to providing a high-quality trading and information experience for their U.S. investors. The OTCQB quality standards provide a strong baseline of transparency as well as the technology and regulation to improve the information and trading experience for investors.
To learn more about how OTC Markets creates better informed and more efficient markets, visit www.otcmarkets.com.
ABOUT MOUNTAIN VALLEY MD HOLDINGS INC.
Mountain Valley MD is building a world-class biotech and life sciences company organization centered around the implementation of its patented Quicksome™ oral drug formulation and delivery technologies and its Quicksol™ solubilization technology for macrocyclic lactones, to innovate industry leading products that are sought out globally.
MVMD's proposition for delivering Quicksome™ formulations that have rapid onset, high bioavailability, low variability and precision dosing is core to the Company's success across key health and wellness categories. Consistent with its vision towards "Helping People Live Their Best Life", MVMD applies its Quicksome™ and Quicksol™ technologies to its ground-breaking work for advanced delivery of vaccines and pharmaceutical drugs as well as the development of products for pain management, weight loss, energy, focus, sleep, anxiety, and more.
The Company's patented Quicksome™ desiccation technology utilizes advanced liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into highly efficient product formats that are consumed orally. The result is a new generation of product formulations that are capable of delivering vaccines, drugs and nutraceuticals into the body faster, with greater impact, efficiency and accuracy. The Company's patented Quicksol™ solubilization technology covers all highly solubilized macrocyclic lactones (including the drugs Ivermectin and Selamectin). MVMD's solubility technology applied to the Ivermectin drug is the only form in the world that only uses excipients that are currently approved by the US Food and Drug Administration (FDA), making it a leading candidate for human injection and sublingual applications as well as significantly broader husbandry and companion animal treatments based on its low viscosity.
For more Company information and contact details, visit www.mountainvalleymd.com.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
Certain statements contained in this news release may constitute forward-looking information. Forward-looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information.
The Company's actual results could differ materially from those anticipated in this forward-looking information as a result of regulatory decisions, competitive factors in the industries in which the Company operates, prevailing economic conditions, and other factors, many of which are beyond the control of the Company.
The Company is making forward-looking statements, including but not limited to with respect to its listing of common shares on the OTCQB and the implications thereof.
The Company believes that the expectations reflected in the forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward-looking information contained in this news release represents the Company's expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/mountain-valley-md-holdings-to-commence-trading-on-otcqb-market-under-ticker-mvmdf-301227704.html
SOURCE Mountain Valley MD Holdings Inc.
Apparently their Quicksome, treatment delivery, system works!
Textbook Under The Radar play.
Came across this stock researching Ivermectin after the US Senate testimony by Dr Pierre Kory.
If true, it's likely their Quicksome Oral Delivery technology.
Rumor is that an exclusive license is being negotiated for one of their solutions.
Looking pretty awesome here. Setting up for a great continued run
HERE GOES THE MONSTER...SOMEONE JUST UNLOCKED ITS CAGE!!
get ready to rumble in the jungle...the next covid beast has been released!!
Followers
|
8
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
136
|
Created
|
12/11/20
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |